Press Releases

Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.

Press Release (10)

AGC Biologics Manufactures Key Ingredient in Potential COVID-19 Treatment Drug, Leronlimab

April 29, 2020 at 3:49 PM

Press Release

Read press release

2 min read

AdaptVac Partners with AGC Biologics to Develop & Produce COVID-19 Vaccine

April 24, 2020 at 5:00 AM

Press Release

Read press release

AGC Biologics in the news for our work toward COVID-19 treatment

April 6, 2020 at 7:37 AM

Press Release

Read press release

2 min read

AGC Inc. Decides to Launch Voluntary Tender Offer for Shares of Molmed

March 17, 2020 at 9:54 AM

Press Release

Read press release

AGC Biologics Plasmid Production

March 16, 2020 at 1:58 PM

Press Release

Read press release

2 min read

Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseases

February 7, 2020 at 1:38 PM

Press Release

Read press release

2 min read

AGC Biologics Expands Plasmid DNA Offering

December 11, 2019 at 1:42 PM

Press Release

Read press release

1 min read

AGC Biologics’ $18m Investment in Seattle and Denmark Facilities Strengthens Global Footprint

November 19, 2019 at 3:48 PM

Press Release

Read press release

1 min read

AGC Biologics Appoints New Site Head/General Manager of Copenhagen, Denmark Operations

October 2, 2019 at 8:21 AM

Press Release

Read press release

2 min read

AGC Biologics Appoints New Chief Technical Officer

September 23, 2019 at 3:23 PM

Press Release

Read press release

Prev 7 8 9 10 11 Next

Our Company

Locations

Policies

Offerings

Services

Specialized Platforms & Programs

News & Blogs

Resources

Fact Sheet Quick Links

Join Us

What Drives Us

Meet Our Teams

Press Releases

Press Release (10)

AGC Biologics Manufactures Key Ingredient in Potential COVID-19 Treatment Drug, Leronlimab

AdaptVac Partners with AGC Biologics to Develop & Produce COVID-19 Vaccine

AGC Biologics in the news for our work toward COVID-19 treatment

AGC Inc. Decides to Launch Voluntary Tender Offer for Shares of Molmed

AGC Biologics Plasmid Production

Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseases

AGC Biologics Expands Plasmid DNA Offering

AGC Biologics’ $18m Investment in Seattle and Denmark Facilities Strengthens Global Footprint

AGC Biologics Appoints New Site Head/General Manager of Copenhagen, Denmark Operations

AGC Biologics Appoints New Chief Technical Officer

Our Mission

Links

News

AGC Biologics’ Milan Site to Prepare Lentiviral Vector Commercial Manufacturing for Adaptimmune’s Lete-Cel Product

Events

Advanced Therapies Week, January 20-23